Healthcare

EMEA (Europe, Middle East and Africa) Gastrointestinal Cancer Drug Market Report 2017

  • QYR1564516
  • 103 Pages
  • September 2017
  • Healthcare
Download Sample    Get Discount   
 
In this report, the EMEA Gastrointestinal Cancer Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Gastrointestinal Cancer Drug for these regions, from 2012 to 2022 (forecast)

Europe: Germany, France, UK, Russia, Italy and Benelux;

Middle East: Saudi Arabia, Israel, UAE and Iran;

Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Gastrointestinal Cancer Drug market competition by top manufacturers/players, with Gastrointestinal Cancer Drug sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

Celgene Corporation

F. Hoffmann-La Roche Ltd.

Eli Lilly and Company

GlaxoSmithKline plc.

Pfizer Inc.

Sanofi

Novartis AG.

Bristol-Myers Squibb Company

Amgen Limited & Amgen Ireland Limited

Johnson & Johnson Private Limited

On the basis of product, this report displays the sales volume (MT), revenue (Million USD), product price (USD/Kg), market share and growth rate of each type, primarily split into

By Therapy

Immunotherapy

Chemotherapy

Targeted Therapy

Radiation Therapy

Hormone Therapy

Adjuvant Chemotherapy

By Route of Administration

Oral

Injectable Therapy

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (MT), market share and growth rate of Gastrointestinal Cancer Drug for each application, including

Radiology

Oncology

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Gastrointestinal Cancer Drug Market Report 2017

1 Gastrointestinal Cancer Drug Overview

1.1 Product Overview and Scope of Gastrointestinal Cancer Drug

1.2 Classification of Gastrointestinal Cancer Drug

1.2.1 EMEA Gastrointestinal Cancer Drug Market Size (Sales) Comparison by Type (2012-2022)

1.2.2 EMEA Gastrointestinal Cancer Drug Market Size (Sales) Market Share by Type (Product Category) in 2016

1.2.3 Immunotherapy

1.2.4 Chemotherapy

1.2.5 Targeted Therapy

1.2.6 Radiation Therapy

1.2.7 Hormone Therapy

1.2.8 Adjuvant Chemotherapy

1.3 EMEA Gastrointestinal Cancer Drug Market by Application/End Users

1.3.1 EMEA Gastrointestinal Cancer Drug Sales (Volume) and Market Share Comparison by Application (2012-2022

1.3.2 Radiology

1.3.3 Oncology

1.4 EMEA Gastrointestinal Cancer Drug Market by Region

1.4.1 EMEA Gastrointestinal Cancer Drug Market Size (Value) Comparison by Region (2012-2022)

1.4.2 Europe Status and Prospect (2012-2022)

1.4.3 Middle East Status and Prospect (2012-2022)

1.4.4 Africa Status and Prospect (2012-2022)

1.5 EMEA Market Size (Value and Volume) of Gastrointestinal Cancer Drug (2012-2022)

1.5.1 EMEA Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2022)

1.5.2 EMEA Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2022)

2 EMEA Gastrointestinal Cancer Drug Competition by Manufacturers/Players/Suppliers, Region, Type and Application

2.1 EMEA Gastrointestinal Cancer Drug Market Competition by Players/Manufacturers

2.1.1 EMEA Gastrointestinal Cancer Drug Sales Volume and Market Share of Major Players (2012-2017)

2.1.2 EMEA Gastrointestinal Cancer Drug Revenue and Share by Players (2012-2017)

2.1.3 EMEA Gastrointestinal Cancer Drug Sale Price by Players (2012-2017)

2.2 EMEA Gastrointestinal Cancer Drug (Volume and Value) by Type/Product Category

2.2.1 EMEA Gastrointestinal Cancer Drug Sales and Market Share by Type (2012-2017)

2.2.2 EMEA Gastrointestinal Cancer Drug Revenue and Market Share by Type (2012-2017)

2.2.3 EMEA Gastrointestinal Cancer Drug Sale Price by Type (2012-2017)

2.3 EMEA Gastrointestinal Cancer Drug (Volume) by Application

2.4 EMEA Gastrointestinal Cancer Drug (Volume and Value) by Region

2.4.1 EMEA Gastrointestinal Cancer Drug Sales and Market Share by Region (2012-2017)

2.4.2 EMEA Gastrointestinal Cancer Drug Revenue and Market Share by Region (2012-2017)

2.4.3 EMEA Gastrointestinal Cancer Drug Sales Price by Region (2012-2017)

3 Europe Gastrointestinal Cancer Drug (Volume, Value and Sales Price), by Players, Countries, Type and Application

3.1 Europe Gastrointestinal Cancer Drug Sales and Value (2012-2017)

3.1.1 Europe Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)

3.1.2 Europe Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)

3.2 Europe Gastrointestinal Cancer Drug Sales and Market Share by Type

3.3 Europe Gastrointestinal Cancer Drug Sales and Market Share by Application

3.4 Europe Gastrointestinal Cancer Drug Sales Volume and Value (Revenue) by Countries

3.4.1 Europe Gastrointestinal Cancer Drug Sales Volume by Countries (2012-2017)

3.4.2 Europe Gastrointestinal Cancer Drug Revenue by Countries (2012-2017)

3.4.3 Germany Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

3.4.4 France Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

3.4.5 UK Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

3.4.6 Russia Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

3.4.7 Italy Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

3.4.8 Benelux Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

4 Middle East Gastrointestinal Cancer Drug (Volume, Value and Sales Price), by Region, Type and Application

4.1 Middle East Gastrointestinal Cancer Drug Sales and Value (2012-2017)

4.1.1 Middle East Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)

4.1.2 Middle East Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)

4.2 Middle East Gastrointestinal Cancer Drug Sales and Market Share by Type

4.3 Middle East Gastrointestinal Cancer Drug Sales and Market Share by Application

4.4 Middle East Gastrointestinal Cancer Drug Sales Volume and Value (Revenue) by Countries

4.4.1 Middle East Gastrointestinal Cancer Drug Sales Volume by Countries (2012-2017)

4.4.2 Middle East Gastrointestinal Cancer Drug Revenue by Countries (2012-2017)

4.4.3 Saudi Arabia Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

4.4.4 Israel Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

4.4.5 UAE Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

4.4.6 Iran Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

5 Africa Gastrointestinal Cancer Drug (Volume, Value and Sales Price) by Players, Countries, Type and Application

5.1 Africa Gastrointestinal Cancer Drug Sales and Value (2012-2017)

5.1.1 Africa Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2017)

5.1.2 Africa Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)

5.2 Africa Gastrointestinal Cancer Drug Sales and Market Share by Type

5.3 Africa Gastrointestinal Cancer Drug Sales and Market Share by Application

5.4 Africa Gastrointestinal Cancer Drug Sales Volume and Value (Revenue) by Countries

5.4.1 Africa Gastrointestinal Cancer Drug Sales Volume by Countries (2012-2017)

5.4.2 Africa Gastrointestinal Cancer Drug Revenue by Countries (2012-2017)

5.4.3 South Africa Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

5.4.4 Nigeria Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

5.4.5 Egypt Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

5.4.6 Algeria Gastrointestinal Cancer Drug Sales and Growth Rate (2012-2017)

6 EMEA Gastrointestinal Cancer Drug Manufacturers/Players Profiles and Sales Data

6.1 Celgene Corporation

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Celgene Corporation Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 F. Hoffmann-La Roche Ltd.

6.2.1 Company Basic Information, Manufacturing Base and Competitors

6.2.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Eli Lilly and Company

6.3.1 Company Basic Information, Manufacturing Base and Competitors

6.3.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Eli Lilly and Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 GlaxoSmithKline plc.

6.4.1 Company Basic Information, Manufacturing Base and Competitors

6.4.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Pfizer Inc.

6.5.1 Company Basic Information, Manufacturing Base and Competitors

6.5.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Pfizer Inc. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Sanofi

6.6.1 Company Basic Information, Manufacturing Base and Competitors

6.6.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Sanofi Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Novartis AG.

6.7.1 Company Basic Information, Manufacturing Base and Competitors

6.7.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Novartis AG. Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Bristol-Myers Squibb Company

6.8.1 Company Basic Information, Manufacturing Base and Competitors

6.8.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Amgen Limited & Amgen Ireland Limited

6.9.1 Company Basic Information, Manufacturing Base and Competitors

6.9.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Johnson & Johnson Private Limited

6.10.1 Company Basic Information, Manufacturing Base and Competitors

6.10.2 Gastrointestinal Cancer Drug Product Type, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Gastrointestinal Cancer Drug Manufacturing Cost Analysis

7.1 Gastrointestinal Cancer Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Gastrointestinal Cancer Drug

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Gastrointestinal Cancer Drug Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 EMEA Gastrointestinal Cancer Drug Market Forecast (2017-2022)

11.1 EMEA Gastrointestinal Cancer Drug Sales, Revenue and Price Forecast (2017-2022)

11.1.1 EMEA Gastrointestinal Cancer Drug Sales and Growth Rate Forecast (2017-2022)

11.1.2 EMEA Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast (2017-2022)

11.1.3 EMEA Gastrointestinal Cancer Drug Price and Trend Forecast (2017-2022)

11.2 EMEA Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.3 Europe Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.4 Middle Eastt Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.5 Africa Gastrointestinal Cancer Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)

11.6 EMEA Gastrointestinal Cancer Drug Sales Forecast by Type (2017-2022)

11.7 EMEA Gastrointestinal Cancer Drug Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Gastrointestinal Cancer Drug

Figure EMEA Gastrointestinal Cancer Drug Sales Volume (MT) by Type (2012-2022)

Figure EMEA Gastrointestinal Cancer Drug Sales Volume Market Share by Type (Product Category) in 2016

Figure Immunotherapy Product Picture

Figure Chemotherapy Product Picture

Figure Targeted Therapy Product Picture

Figure Radiation Therapy Product Picture

Figure Hormone Therapy Product Picture

Figure Adjuvant Chemotherapy Product Picture

Figure EMEA Gastrointestinal Cancer Drug Sales Volume (MT) by Application (2012-2022)

Figure EMEA Sales Market Share of Gastrointestinal Cancer Drug by Application in 2016

Figure Radiology Examples

Table Key Downstream Customer in Radiology

Figure Oncology Examples

Table Key Downstream Customer in Oncology

Figure EMEA Gastrointestinal Cancer Drug Market Size (Million USD) by Region (2012-2022)

Figure Europe Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe Gastrointestinal Cancer Drug Revenue (Million USD) Status and Forecast by Countries

Figure Middle East Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Middle East Gastrointestinal Cancer Drug Revenue (Million USD) Status and Forecast by Countries

Figure Africa Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure Africa Gastrointestinal Cancer Drug Revenue (Million USD) Status and Forecast by Countries

Figure EMEA Gastrointestinal Cancer Drug Sales Volume and Growth Rate (2012-2022)

Figure EMEA Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2022)

Figure EMEA Gastrointestinal Cancer Drug Market Major Players Product Sales Volume (MT) (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Sales Volume (MT) of Major Players (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Sales Share by Players (2012-2017)

Figure 2016 Gastrointestinal Cancer Drug Sales Share by Players

Figure 2017 Gastrointestinal Cancer Drug Sales Share by Players

Figure EMEA Gastrointestinal Cancer Drug Market Major Players Product Revenue (Million USD) (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Revenue (Million USD) by Players (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Revenue Share by Players (2012-2017)

Table 2016 EMEA Gastrointestinal Cancer Drug Revenue Share by Players

Table 2017 EMEA Gastrointestinal Cancer Drug Revenue Share by Players

Table EMEA Gastrointestinal Cancer Drug Sale Price (USD/Kg) by Players (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Sales (MT) and Market Share by Type (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Sales Share by Type (2012-2017)

Figure Sales Market Share of Gastrointestinal Cancer Drug by Type (2012-2017)

Figure EMEA Gastrointestinal Cancer Drug Sales Market Share by Type (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Type (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Gastrointestinal Cancer Drug by Type in 2016

Table EMEA Gastrointestinal Cancer Drug Sale Price (USD/Kg) by Type (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Sales (MT) and Market Share by Application (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Sales Share by Application (2012-2017)

Figure Sales Market Share of Gastrointestinal Cancer Drug by Application (2012-2017)

Figure EMEA Gastrointestinal Cancer Drug Sales Market Share by Application in 2016

Table EMEA Gastrointestinal Cancer Drug Sales (MT) and Market Share by Region (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Sales Share by Region (2012-2017)

Figure Sales Market Share of Gastrointestinal Cancer Drug by Region (2012-2017)

Figure EMEA Gastrointestinal Cancer Drug Sales Market Share in 2016

Table EMEA Gastrointestinal Cancer Drug Revenue (Million USD) and Market Share by Region (2012-2017)

Table EMEA Gastrointestinal Cancer Drug Revenue Share by Region (2012-2017)

Figure Revenue Market Share of Gastrointestinal Cancer Drug by Region (2012-2017)

Figure EMEA Gastrointestinal Cancer Drug Revenue Market Share Regions in 2016

Table EMEA Gastrointestinal Cancer Drug Sales Price (USD/Kg) by Region (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Revenue and Growth Rate (2012-2017)

Table Europe Gastrointestinal Cancer Drug Sales (MT) by Type (2012-2017)

Table Europe Gastrointestinal Cancer Drug Market Share by Type (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Market Share by Type in 2016

Table Europe Gastrointestinal Cancer Drug Sales (MT) by Application (2012-2017)

Table Europe Gastrointestinal Cancer Drug Market Share by Application (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Market Share by Application in 2016

Table Europe Gastrointestinal Cancer Drug Sales (MT) by Countries (2012-2017)

Table Europe Gastrointestinal Cancer Drug Sales Market Share by Countries (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Sales Market Share by Countries (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Sales Market Share by Countries in 2016

Table Europe Gastrointestinal Cancer Drug Revenue (Million USD) by Countries (2012-2017)

Table Europe Gastrointestinal Cancer Drug Revenue Market Share by Countries (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Revenue Market Share by Countries (2012-2017)

Figure Europe Gastrointestinal Cancer Drug Revenue Market Share by Countries in 2016

Figure Germany Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure France Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure UK Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Russia Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Italy Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Benelux Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Middle East Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Middle East Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)

Table Middle East Gastrointestinal Cancer Drug Sales (MT) by Type (2012-2017)

Table Middle East Gastrointestinal Cancer Drug Market Share by Type (2012-2017)

Figure Middle East Gastrointestinal Cancer Drug Market Share by Type (2012-2017)

Table Middle East Gastrointestinal Cancer Drug Sales (MT) by Applications (2012-2017)

Table Middle East Gastrointestinal Cancer Drug Market Share by Applications (2012-2017)

Figure Middle East Gastrointestinal Cancer Drug Sales Market Share by Application in 2016

Table Middle East Gastrointestinal Cancer Drug Sales Volume (MT) by Countries (2012-2017)

Table Middle East Gastrointestinal Cancer Drug Sales Volume Market Share by Countries (2012-2017)

Figure Middle East Gastrointestinal Cancer Drug Sales Volume Market Share by Countries in 2016

Table Middle East Gastrointestinal Cancer Drug Revenue (Million USD) by Countries (2012-2017)

Table Middle East Gastrointestinal Cancer Drug Revenue Market Share by Countries (2012-2017)

Figure Middle East Gastrointestinal Cancer Drug Revenue Market Share by Countries (2012-2017)

Figure Middle East Gastrointestinal Cancer Drug Revenue Market Share by Countries in 2016

Figure Saudi Arabia Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Israel Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure UAE Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Iran Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Revenue (Million USD) and Growth Rate (2012-2017)

Table Africa Gastrointestinal Cancer Drug Sales (MT) by Type (2012-2017)

Table Africa Gastrointestinal Cancer Drug Sales Market Share by Type (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Sales Market Share by Type (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Sales Market Share by Type in 2016

Table Africa Gastrointestinal Cancer Drug Sales (MT) by Application (2012-2017)

Table Africa Gastrointestinal Cancer Drug Sales Market Share by Application (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Sales Market Share by Application (2012-2017)

Table Africa Gastrointestinal Cancer Drug Sales Volume (MT) by Countries (2012-2017)

Table Africa Gastrointestinal Cancer Drug Sales Market Share by Countries (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Sales Market Share by Countries (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Sales Market Share by Countries in 2016

Table Africa Gastrointestinal Cancer Drug Revenue (Million USD) by Countries (2012-2017)

Table Africa Gastrointestinal Cancer Drug Revenue Market Share by Countries (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Revenue Market Share by Countries (2012-2017)

Figure Africa Gastrointestinal Cancer Drug Revenue Market Share by Countries in 2016

Figure South Africa Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Nigeria Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Egypt Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Algeria Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Table Celgene Corporation Gastrointestinal Cancer Drug Basic Information List

Table Celgene Corporation Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Celgene Corporation Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Celgene Corporation Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Celgene Corporation Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Basic Information List

Table F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Eli Lilly and Company Gastrointestinal Cancer Drug Basic Information List

Table Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Eli Lilly and Company Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Eli Lilly and Company Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Basic Information List

Table GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure GlaxoSmithKline plc. Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Pfizer Inc. Gastrointestinal Cancer Drug Basic Information List

Table Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Pfizer Inc. Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Pfizer Inc. Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Sanofi Gastrointestinal Cancer Drug Basic Information List

Table Sanofi Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Sanofi Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Sanofi Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Sanofi Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Novartis AG. Gastrointestinal Cancer Drug Basic Information List

Table Novartis AG. Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Novartis AG. Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Novartis AG. Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Novartis AG. Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Basic Information List

Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Bristol-Myers Squibb Company Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Basic Information List

Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Basic Information List

Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)

Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales (MT) and Growth Rate (2012-2017)

Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Sales Market Share in EMEA (2012-2017)

Figure Johnson & Johnson Private Limited Gastrointestinal Cancer Drug Revenue Market Share in EMEA (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Gastrointestinal Cancer Drug

Figure Manufacturing Process Analysis of Gastrointestinal Cancer Drug

Figure Gastrointestinal Cancer Drug Industrial Chain Analysis

Table Raw Materials Sources of Gastrointestinal Cancer Drug Major Manufacturers in 2016

Table Major Buyers of Gastrointestinal Cancer Drug

Table Distributors/Traders List

Figure EMEA Gastrointestinal Cancer Drug Sales (MT) and Growth Rate Forecast (2017-2022)

Figure EMEA Gastrointestinal Cancer Drug Revenue and Growth Rate Forecast (2017-2022)

Figure EMEA Gastrointestinal Cancer Drug Price (USD/Kg) and Trend Forecast (2017-2022)

Table EMEA Gastrointestinal Cancer Drug Sales (MT) Forecast by Region (2017-2022)

Figure EMEA Gastrointestinal Cancer Drug Sales Market Share Forecast by Region (2017-2022)

Table EMEA Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Region (2017-2022)

Figure EMEA Gastrointestinal Cancer Drug Revenue Market Share Forecast by Region (2017-2022)

Table Europe Gastrointestinal Cancer Drug Sales (MT) Forecast by Countries (2017-2022)

Figure Europe Gastrointestinal Cancer Drug Sales Market Share Forecast by Countries (2017-2022)

Table Europe Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Europe Gastrointestinal Cancer Drug Revenue Market Share Forecast by Countries (2017-2022)

Table Middle East Gastrointestinal Cancer Drug Sales (MT) Forecast by Countries (2017-2022)

Figure Middle East Gastrointestinal Cancer Drug Sales Market Share Forecast by Countries (2017-2022)

Table Middle East Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Middle East Gastrointestinal Cancer Drug Revenue Market Share Forecast by Countries (2017-2022)

Table Africa Gastrointestinal Cancer Drug Sales (MT) Forecast by Countries (2017-2022)

Figure Africa Gastrointestinal Cancer Drug Sales Market Share Forecast by Countries (2017-2022)

Table Africa Gastrointestinal Cancer Drug Revenue (Million USD) Forecast by Countries (2017-2022)

Figure Africa Gastrointestinal Cancer Drug Revenue Market Share Forecast by Countries (2017-2022)

Table EMEA Gastrointestinal Cancer Drug Sales (MT) Forecast by Type (2017-2022)

Figure EMEA Gastrointestinal Cancer Drug Sales Market Share Forecast by Type (2017-2022)

Table EMEA Gastrointestinal Cancer Drug Sales (MT) Forecast by Application (2017-2022)

Figure EMEA Gastrointestinal Cancer Drug Sales Market Share Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370